Biotech SF: Roche Venture Fund

Showing posts with label Roche Venture Fund. Show all posts

Tuesday, July 31, 2012

Drug developer CytomX expands Series B by $11 million, looks to make key hires

CytomX Therapeutics Inc. expanded its $41 million Series B financing round byadding $11 million from venture capital firmCanaan Partners. The South San Francisco company, which in September 2010 raised $30 million from Third Rock Ventures and Roche Venture Fund, is developing highly targeted antibodies, which it calls Probodies. Those potential cancer and inflammatory disease treatments unmask their antibody-drug payloads only when they enter the "microenvironment" of diseases.

Tuesday, March 6, 2012

CytomX names Hoyoung Huh as chairman

Antibody development company CytomX Therapeutics Inc. named biotech veteran Dr. Hoyoung Huh as chairman.
The privately held company, which moved to South San Francisco after lining up $30 million in financing in 2010, is developing monoclonal antibodies that can target specific tissues in cancer, inflammatory disease and autoimmune conditions.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.